These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10866393)

  • 1. Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitors.
    Cacciola J; Fevig JM; Stouten PF; Alexander RS; Knabb RM; Wexler RR
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1253-6. PubMed ID: 10866393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors.
    Heinelt U; Herok S; Matter H; Wildgoose P
    Bioorg Med Chem Lett; 2001 Jan; 11(2):227-30. PubMed ID: 11206465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and discovery of 1-(2-(6-Chloro-3-methylsulfonyl)-naphthyl)-1H-pyrazole-5-carboxylamides as highly potent factor Xa inhibitors.
    Jia ZJ; Scarborough RM; Zhang P; Halfon S; Arfsten AE; Sinha U; Zhu BY
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):1004-7. PubMed ID: 19721266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1.
    Kher SS; Penzo M; Fulle S; Finn PW; Blackman MJ; Jirgensons A
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4486-4489. PubMed ID: 25129616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory solid-phase synthesis of factor Xa inhibitors: discovery and application of p3-heterocyclic amides as novel types of non-basic arginine surrogates.
    Ho JZ; Levy OE; Gibson TS; Nguyen K; Semple JE
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3459-64. PubMed ID: 10617091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides.
    Jia ZJ; Wu Y; Huang W; Goldman E; Zhang P; Woolfrey J; Wong P; Huang B; Sinha U; Park G; Reed A; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1651-5. PubMed ID: 12039583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depeptidization efforts on P3-P2' alpha-ketoamide inhibitors of HCV NS3-4A serine protease: effect on HCV replicon activity.
    Bogen SL; Ruan S; Liu R; Agrawal S; Pichardo J; Prongay A; Baroudy B; Saksena AK; Girijavallabhan V; Njoroge FG
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1621-7. PubMed ID: 16387495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa.
    Matter H; Defossa E; Heinelt U; Blohm PM; Schneider D; Müller A; Herok S; Schreuder H; Liesum A; Brachvogel V; Lönze P; Walser A; Al-Obeidi F; Wildgoose P
    J Med Chem; 2002 Jun; 45(13):2749-69. PubMed ID: 12061878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and SAR of amino acid derivatives as factor Xa inhibitors.
    Su T; Wu Y; Doughan B; Jia ZJ; Woolfrey J; Huang B; Wong P; Park G; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2947-50. PubMed ID: 11677132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel, potent and selective chimeric FXa inhibitors featuring hydrophobic P1-ketoamide moieties.
    Semple JE; Levy OE; Minami NK; Owens TD; Siev DV
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2305-9. PubMed ID: 11055344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency.
    Corte JR; Yang W; Fang T; Wang Y; Osuna H; Lai A; Ewing WR; Rossi KA; Myers JE; Sheriff S; Lou Z; Zheng JJ; Harper TW; Bozarth JM; Wu Y; Luettgen JM; Seiffert DA; Quan ML; Wexler RR; Lam PYS
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3833-3839. PubMed ID: 28687203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
    Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.
    Fevig JM; Pinto DJ; Han Q; Quan ML; Pruitt JR; Jacobson IC; Galemmo RA; Wang S; Orwat MJ; Bostrom LL; Knabb RM; Wong PC; Lam PYS ; Wexler RR
    Bioorg Med Chem Lett; 2001 Mar; 11(5):641-5. PubMed ID: 11266160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors.
    Zhang P; Zuckett JF; Woolfrey J; Tran K; Huang B; Wong P; Sinha U; Park G; Reed A; Malinowski J; Hollenbach S; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1657-61. PubMed ID: 12039584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of betaII tryptase.
    Levell J; Astles P; Eastwood P; Cairns J; Houille O; Aldous S; Merriman G; Whiteley B; Pribish J; Czekaj M; Liang G; Maignan S; Guilloteau JP; Dupuy A; Davidson J; Harrison T; Morley A; Watson S; Fenton G; McCarthy C; Romano J; Mathew R; Engers D; Gardyan M; Sides K; Kwong J; Tsay J; Rebello S; Shen L; Wang J; Luo Y; Giardino O; Lim HK; Smith K; Pauls H
    Bioorg Med Chem; 2005 Apr; 13(8):2859-72. PubMed ID: 15781396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of alpha-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinase.
    Bennett JM; Campbell AD; Campbell AJ; Carr MG; Dunsdon RM; Greening JR; Hurst DN; Jennings NS; Jones PS; Jordan S; Kay PB; O'Brien MA; King-Underwood J; Raynham TM; Wilkinson CS; Wilkinson TC; Wilson FX
    Bioorg Med Chem Lett; 2001 Feb; 11(3):355-7. PubMed ID: 11212109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P4 and P1' optimization of bicycloproline P2 bearing tetrapeptidyl alpha-ketoamides as HCV protease inhibitors.
    Yip Y; Victor F; Lamar J; Johnson R; Wang QM; Glass JI; Yumibe N; Wakulchik M; Munroe J; Chen SH
    Bioorg Med Chem Lett; 2004 Oct; 14(19):5007-11. PubMed ID: 15341970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel benzo-fused lactam scaffolds as factor Xa inhibitors.
    Tamura SY; Goldman EA; Bergum PW; Semple JE
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2573-8. PubMed ID: 10498211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profiles.
    Bogen SL; Pan W; Ruan S; Nair LG; Arasappan A; Bennett F; Chen KX; Jao E; Venkatraman S; Vibulbhan B; Liu R; Cheng KC; Guo Z; Tong X; Saksena AK; Girijavallabhan V; Njoroge FG
    J Med Chem; 2009 Jun; 52(12):3679-88. PubMed ID: 19456105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.
    Baettig U; Brown L; Brundish D; Dell C; Furzer A; Garman S; Janus D; Kane PD; Smith G; Walker CV; Cockcroft X; Ambler J; Mitchelson A; Talbot MD; Tweed M; Wills N
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1563-6. PubMed ID: 10915051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.